Comparative Study of Norfloxacin Versus Norfloxacin With Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Who is this study for? Patients with spontaneous bacterial peritonitis
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• cirrhotic patients with ascites who had previous episodes of SBP.

Locations
Other Locations
Egypt
Sherief Abd-Elsalam
RECRUITING
Tanta
Contact Information
Primary
Sherief Abd-Elsalam, ass. prof.
sheriefabdelsalam@yahoo.com
00201147773440
Backup
sherief abd-elsalam, ass. prof.
sherif_tropical@yahoo.com
00201147773440
Time Frame
Start Date: 2018-12-01
Estimated Completion Date: 2028-12-01
Participants
Target number of participants: 80
Treatments
Active_comparator: Norfloxacin
Norfloxacin 400 mg daily
Experimental: Norfloxacin and Itopride
Norfloxacin 400 mg daily and Itopride 50 mg three times daily.
Sponsors
Leads: Tanta University

This content was sourced from clinicaltrials.gov